Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Access Control
LeftNav
Alarms
LeftNav
Biometrics
LeftNav
Detection
LeftNav
Deutsche Zone (German Zone)
LeftNav
Education, Training and Professional Services
LeftNav
Government Programmes
LeftNav
Guarding, Equipment and Enforcement
LeftNav
Industrial Computing Security
LeftNav
IT Security
LeftNav
Physical Security
LeftNav
Surveillance
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
 
News

Lab in a bead facilitates field testing of bio threats

Q Chip : 10 September, 2007  (Company News)
Q Chip secures investment funding following development of useful techniques for testing food-chain contaminants and bio-threats
Q Chip, has announced the successful completion of an investment funding round in excess of £2 million. A number of existing major shareholders participated in the round alongside such as new international investors.

News of the investment follows 2 significant product launches this year. MicroPlant is a microfluidics-based device which enables pharmaceutical and life science reagents to be packaged in precise, uniform polymer beads resulting in ultra-low wastage, uniform dosing & morphology and low process costs. The new ReaX Mastermix Lab-in-a-Bead range encapsulates all the reagents required to perform PCR in a single dose within the bead. This allows even untrained operators to set up PCR reactions in any thermal cycler system, whilst giving highly reproducible results.

"ReaX de-skills PCR processing through packaging of reagents in a single dose bead. We have calculated it can reduce the time involved by up to ninety percent" commented Dr Jo Daniels, Q Chip's Chief Scientific Officer, "We believe our products will hasten field-based testing of bio-threats and food chain contaminants as well as point of care diagnostics for human health care. It's this sort of market potential that generated so much interest amongst existing and new investors."
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProSecurityZone.com
Netgains Logo